Shopping Cart
Remove All
Your shopping cart is currently empty
AKT1-IN-9 (4) is a selective inhibitor of the AKT1(E17K) mutation, exhibiting EC50 values of 9 nM in LAPC4-CR cells and 995 nM in SkBr3 cells.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | AKT1-IN-9 (4) is a selective inhibitor of the AKT1(E17K) mutation, exhibiting EC50 values of 9 nM in LAPC4-CR cells and 995 nM in SkBr3 cells. |
| In vivo | AKT1-IN-9 (4) (40 mg/kg, i.p. injection, single dose) reduces the levels of phosphorylated AKT1 and phosphorylated PRAS40 in tumors collected 2 and 7 hours post-administration, showing an inhibition rate of 80-90%. |
| Molecular Weight | 588.588 |
| Formula | C33H25FN6O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.